Adults Oxybutynin hydrochloride XL is indicated in adults for the symptomatic treatment of urge incontinence and/or increased urinary frequency associated with urgency as may occur in patients with unstable bladder. Paediatric population Oxybutynin hydrochloride is indicated in children over 5 years of age for: - Urinary incontinence, urgency and frequency in unstable bladder conditions due to idiopathic overactive bladder or neurogenic bladder disorders (detrusor over activity) - Nocturnal enuresis associated with detrusor over activity, in conjunction with non-drug therapy, when other treatment has failed.
Teva Pharma UK has launched generic versions of Seroquel and Seroquel XL as Quetiapine and Quetiapine XL.Other generic versions are...
The FDA has approved Astagraf XL (tacrolimus extended-release capsules), from Astellas, for the prophylaxis of organ Transplant Rejection in patients...
Top line results were reported by Exelixis for XL 184 (cabozantinib) for the primary endpoint in the 330-patient Phase III...
Exelixis, Inc. announced the initiation of STELLAR-303, a phase III pivotal trial evaluating XL 092 in combination with atezolizumab versus regorafenib in patients with metastatic colorectal cancer (CRC) that is not microsatellite instability-high or mismatch repair-deficient, who have progressed after or are intolerant to the standard of care therapy.
Prophylactic treatment of angina pectoris.
Alzheimer's medication Reminyl XL/Razadyne (galantamine hydrobromide) from Janssen Pharma, appears to slash inflammation and insulin resistance in patients with metabolic...